Translational research strategy: an essential approach to fight the spread of antimicrobial resistance
Open Access
- 9 July 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 69 (11), 2889-2891
- https://doi.org/10.1093/jac/dku244
Abstract
Translation research strategy in infectious diseases, combining the results from basic research with patient-orientated research, aims to bridge the gap between laboratory findings and clinical infectious disease practice to improve disease management. In an era of increasing antimicrobial resistance, there are four main areas of clinical and scientific uncertainty that need to be urgently addressed by translational research: (i) early diagnosis of antibiotic-resistant infections and the appropriateness of empirical antibiotic therapy; (ii) the identification of reservoirs of antibiotic-resistant pathogens; (iii) the development of new antibiotics with lower propensities to evoke resistance; and (iv) the development of new non-antibiotic drugs to be used in the prevention of the spread of resistant bacterial strains. Strict European collaboration among major stakeholders is therefore essential. Appropriate educational tools to train a new generation of scientists with regard to a multifaceted approach to antimicrobial resistance research should be developed. Key areas include the support and implementation of European networks focused on translational research and related education activities, making potential therapeutics more attractive to investors and helping academic investigators to determine whether new molecules can be developed with clinical applicability.Keywords
This publication has 6 references indexed in Scilit:
- Differential Effects of Antibiotic Therapy on the Structure and Function of Human Gut MicrobiotaPLOS ONE, 2013
- Translational research in infectious disease: current paradigms and challenges aheadTranslational Research, 2012
- Translational research: 4 ways to fix the clinical trialNature, 2011
- Development of an integrated metabolomic profiling approach for infectious diseases researchThe Analyst, 2011
- Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacyNature Chemical Biology, 2011
- Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settingsCurrent Opinion in Infectious Diseases, 2009